MicroRNA144 suppresses tumorigenesis of hepatocellular carcinoma by targeting AKT3

Molecular Medicine Reports

Volumn 11, Issue 2, 2015, Pages 1378-1383

  Ma, Ying ^a   She, Xingguo G ^a   Ming, Yingzi Z ^a   Wan, Qiquan Q ^a   Ye, Qifa F ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

AKT3; Growth; Hepatocellular carcinoma; Invasion; Microrna144

Indexed keywords

3' UNTRANSLATED REGION; AKT3 PROTEIN, HUMAN; MICRORNA; MIRN144 MICRORNA, HUMAN; PROTEIN KINASE B;

3' UNTRANSLATED REGION; CARCINOGENESIS; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; GENETIC TRANSFECTION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-AKT; SEQUENCE ALIGNMENT; TRANSFECTION;

EID: 84916234499     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2844     Document Type: Article

References (15)

1. Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet 379: 1245-1255, 2012.
2. Kong D, Chen H, Chen W, et al: Gene expression profiling analysis of hepatocellular carcinoma. Eur J Med Res 18: 44, 2013.
3. Aravalli RN, Steer CJ and Cressman EN: Molecular mechanisms of hepatocellular carcinoma. Hepatology 48: 2047-2063, 2008.
4. Hauptman N and Glavac D: MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer. Radiol Oncol 47: 311-318, 2013.
5. Wang W, Lin H, Zhou L, et al: MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Eur J Surg Oncol: Nov 19, 2013 (Epub ahead of print).
6. Ke Y, Zhao W, Xiong J and Cao R: Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells. FEBS Lett 587: 3153-3157, 2013.
7. Yang H, Li Q, Zhao W, Yuan D, Zhao H and Zhou Y: miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A. FEBS Lett 588: 192-197, 2014.
8. Guo Y, Ying L, Tian Y, et al: miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J 280: 4531-4538, 2013.
9. Iwaya T, Yokobori T, Nishida N, et al: Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33: 2391-2397, 2012.
10. Zha W, Cao L, Shen Y and Huang M: Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer. PLoS One 8: e74175, 2013.
11. Katayama Y, Maeda M, Miyaguchi K, et al: Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett 4: 817-823, 2012.
12. Zhang LY, Ho-Fun Lee V, Wong AM, et al: MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34: 454-463, 2013.
13. Hers I, Vincent EE and Tavare JM: Akt signalling in health and disease. Cell Signal 23: 1515-1527, 2011.
14. Stambolic V and Woodgett JR: Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration. Trends Cell Biol 16: 461-466, 2006.
15. Nassirpour R, Mehta PP and Yin MJ: miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3. PLoS One 8: e79655, 2013.